Home > Healthcare > Medical Devices > Diagnostic Devices > Sepsis Diagnostics Market

Sepsis Diagnostics Market Size

  • Report ID: GMI5899
  • Published Date: May 2023
  • Report Format: PDF

Sepsis Diagnostics Market Size

Sepsis Diagnostics Market size was valued at over USD 620 million in 2022 and is projected to reach more than USD 1.2 billion by 2032. Rising awareness regarding infectious diseases and its diagnosis will drive the market expansion.

 

Sepsis diagnostics refer to the processes and methods used to identify and diagnose sepsis, a potentially life-threatening condition caused by a severe infection. Sepsis occurs when the body's response to an infection triggers widespread inflammation, leading to organ dysfunction and failure. Rapid and accurate diagnosis of sepsis is crucial for timely and appropriate medical intervention, as the condition can progress rapidly and become fatal. The increasing demand for diagnostics sepsis devices is anticipated to foster the market share.

 

Moreover, the rising incidence of hospital-acquired infections, growing number of geriatric population base, immunocompromised patients, and chronic illness patients, is further augmenting the market value. For instance, according to the World Health Organization (WHO), sepsis affects an estimated 49 million individuals and causes 11 million deaths globally, every year. Further, around half (49%) of patients with sepsis in intensive care units acquire infection in the hospital, annually.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

The global market for sepsis diagnostics was worth more than USD 620 million in 2022 and is estimated to generate more than USD 1.2 billion by 2032 driven by the rising incidence of hospital-acquired infections, expanding geriatric population base, and chronic illness patients.

The blood culture media product segment amassed approximately USD 224 million in 2022 and is projected to grow at a robust CAGR through 2032 owing to the rising product demand due to their cost-effectiveness and convenience.

North America held a notable revenue share in the sepsis diagnostics market and is set to exhibit a steady growth rate attributed to the presence of highly developed healthcare systems and the implementation of innovative sepsis diagnostic technologies.

The leading companies engaged in the sepsis diagnostics industry are Abbott Laboratories, BioMerieux SA, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Bruker Corporation, Beckman Coulter, Inc., T2 Biosystems, Inc., Nanosphere, Inc., Hoffmann-LA Roche Ltd., Danaher Corporation

Sepsis Diagnostics Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 444
  • Countries covered: 32
  • Pages: 200
 Download Free Sample